Neoplasms in three patients following Kawasaki disease

Pediatrics International

Volumn 47, Issue 2, 2005, Pages 217-219

  Suzuki, Hiroyuki ^a   Takeuchi, Takashi ^a   Minami, Takaomi ^a   Shima, Yuko ^a   Iwahashi, Seiji ^a   Shibuta, Shoichi ^b   Uemura, Shigeru ^a   Kounami, Shinji ^a   Aoyagi, Noriyuki ^a   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Kinan General Hospital   (Japan)

Author keywords

Growth factor; Immunological abnormality; Intravenous immunoglobulin therapy; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTILEUKEMIC AGENT; IMMUNOGLOBULIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER; CASE REPORT; CAUSE OF DEATH; GIANT CELL TUMOR; HEPATOSPLENOMEGALY; HUMAN; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEURILEMOMA; NEUROFIBROMATOSIS; PETECHIA; PRIORITY JOURNAL; SEPTICEMIA; TENDON SHEATH;

ADOLESCENT; CHILD, PRESCHOOL; FATAL OUTCOME; GIANT CELL TUMORS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEOPLASMS; NEURILEMMOMA; TENDONS;

EID: 20244383854     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02028.x     Document Type: Article

References (11)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of fingers and toes in children: clinical observation of 50 cases. Jpn. J. Allergol. 1967: 16: 178-222.
2. Jason J, Gregg L, Han A et al. Immunoregulatory changes in Kawasaki disease. Clin. Immunol. Immunopathol. 1997; 84: 296-306.
3. Murray JC, Bomgaars LR, Carcamo B, Mahoney DH Jr. Lymphoid malignancies following Kawasaki disease. Am. J. Hematol. 1995; 50: 299-300.
4. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan. The fifth look. Arch. Pediatr. Adolesc. Med. 2002; 156: 162-5.
5. Ferner RE, O'Doherty ML. Neurofibroma and schwannoma. Curr. Opin. Neurol 2002; 15: 679-84.
6. Nakamura Y, Yanagawa H, Kato H, Harada K, Kawasaki T. the Kawasaki Disease Follow-Up Group. Mortality among patients with a history of Kawasaki disease: the third look. Acta Pediatr. Jpn. 1998; 40: 419-23.
7. Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr. Int. 2001; 43: 115-19.
8. Igarashi H, Hatake K, Tomizuka H, Yamada M, Gunji Y, Momoi MY. High serum levels of M-CSF and G-CSF in Kawasaki disease. Br. J. Haematol. 1999; 105: 613-15.
9. Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am. J. Cardiol. 1999; 83: 337-9.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7.
11. Gibbsons CL, Khwaja HA, Cole AS, Cooke PH, Athanasou NA. Giant-cell tumour of the tendon sheath in the foot and ankle. J. Bone Joint Surg. Br. 2002; 84: 1000-3.